Key facts
- This page summarizes Kevin D. Freeman's Form 4/A - Amendment filing for GALECTIN THERAPEUTICS INC (GALT).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 23 Dec 2025, 13:21.
Key filing fact
Ownership activity is grounded in SEC Form 4/A - Amendment disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Purchase
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.